Catalog No.
RHC22902
Species reactivity
Human, Rat
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000
Target
Tyrosine 3-hydroxylase, TYH, Tyrosine 3-monooxygenase, TH
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P07101
Applications
ELISA, FCM, IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3A02
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia., PMID:40536789
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors., PMID:40536766
Influence of triptans use on anti-CGRP mAbs response: a prospective, cohort study., PMID:40536712
Case report of ischemic stroke in a child secondary to neuroborreliosis., PMID:40536655
Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies?, PMID:40536609
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies., PMID:40536585
Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Dupilumab on Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) in Uncontrolled Moderate-To-Severe Asthma., PMID:40536285
Endocrinopathies associated with pediatric common variable immunodeficiency., PMID:40536030
Prognostic Significance of Immunohistochemical Surrogate Molecular Sub-Typing of Small Cell Lung Carcinoma., PMID:40536008
C3 Glomerulonephritis Associated With Unusual IgG4 Antifactor H in IgG4-related Disease., PMID:40535909
Development of Traditional Chinese Medicine in combination with EGFR Inhibitors against Cancer., PMID:40535810
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond., PMID:40535734
The Novel Use of Daratumumab in the Treatment of Refractory Autoimmune Pulmonary Alveolar Proteinosis., PMID:40535728
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges., PMID:40535484
Double Trouble: Drug-Induced Autoimmune Hepatitis (AIH)-Primary Biliary Cholangitis (PBC) Overlap Syndrome Triggered by Hydralazine., PMID:40535405
Navigating a Diagnostic Dilemma: A Case Report of Overlapping Presentation of Granulomatosis With Polyangiitis and Tuberculosis., PMID:40535379
Efficacy of intravenous immunoglobulin in recurrent pregnancy loss: a retrospective analysis of patients with abnormal cellular immunity., PMID:40535341
A Case of Surgery for a Giant Popliteal Venous Aneurysm Positive for Heparin-Induced Thrombocytopenia Antibodies with Repeated Acute Pulmonary Embolism., PMID:40535145
Combination of immune checkpoint inhibitors with multi-targeted tyrosine kinase inhibitors for second- or later-line therapy of non-small cell lung cancer: a systematic review and meta-analysis., PMID:40535065
Pro-dermcidin and derivatives as potential therapeutics for lethal experimental sepsis., PMID:40534887
Risk of new-onset inflammatory bowel disease in psoriasis patients treated with five different interleukin inhibitors: a systematic review and meta-analysis., PMID:40534876
Oral immunotherapy for cow's milk allergy in children: a systematic review and meta-analysis., PMID:40534871
Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report., PMID:40534866
Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol., PMID:40534862
Clinical and electrophysiological features of adult patients with combined central and peripheral demyelination- a systematic review., PMID:40534858
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients., PMID:40534853
Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn's disease patients., PMID:40534845
Molecular Tuning of Cyanine 5 Dyes to Improve the Pharmacokinetic Profile of Nanobody-Based Fluorescent Tracers., PMID:40534666
Current state-of-the-art of immunotherapy in follicular lymphoma., PMID:40534532
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies., PMID:40534489
[Comparison of the efficacy, safety, and cost-effectiveness of trastuzumab biosimilar HLX02 and the originator combined with pertuzumab and chemotherapy in the neoadjuvant treatment of patients with HER-2-positive breast cancer]., PMID:40534267
Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response., PMID:40534172
Effectiveness of islatravir post-exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaques., PMID:40534150
Effective Use of BCMA-Targeting Bispecific T-Cell-Engaging Antibody in Treatment Refractory LRP4-positive Myasthenia Gravis., PMID:40534130
A novel therapeutic strategy for osteosarcoma using anti-GD2 ADC and EZH2 inhibitor., PMID:40533837
Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment., PMID:40533745
Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population., PMID:40533571
R9AP is a common receptor for EBV infection in epithelial cells and B cells., PMID:40533557
Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer., PMID:40533489
Exploring the depths of hypogammaglobulinemia in lymphoid malignancies: Pathophysiology, clinical implications, management options, and future directions., PMID:40533299
Validation of Risk Prediction System for Denosumab-Induced Hypocalcemia with an External Clinical Dataset., PMID:40533172
Transverse myelitis following guselkumab treatment for severe plaque psoriasis., PMID:40533109
Efficient gene delivery to immune cells via a recombinant multifunctional chimeric peptide nanocarrier: Implications in immunotherapy., PMID:40532900
Identifying pathogenic contributors of radiodermatitis ameliorated by Smad7-based targeting in canine and mouse models., PMID:40532891
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer., PMID:40532664
Amplifying tumor recognition and drug susceptibility by multivalent ApDC assembly to combat with tumor cell heterogeneity., PMID:40532654
Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclases., PMID:40532576
A Rare Case of Pembrolizumab Induced Pericardial Tamponade in a 77-Year-Old., PMID:40532296
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer., PMID:40532152
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study., PMID:40532125
For research use only. Not for human or drug use.
